Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 273

Results For "MIT"

4667 News Found

Ritesh Jain appointed CFO of Krebs Biochemicals and Industries
People | February 04, 2023

Ritesh Jain appointed CFO of Krebs Biochemicals and Industries

He is a Chartered Accountant with more than 19 years of extensive experience


Lupin launches Aptivate Champion Run for Kids
News | February 04, 2023

Lupin launches Aptivate Champion Run for Kids

Through this important initiative, Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in the Aptivate Champion Run


GMM Pfaudler posts Q3 FY23 consolidated profit at Rs. 18.67 Cr
News | February 03, 2023

GMM Pfaudler posts Q3 FY23 consolidated profit at Rs. 18.67 Cr

The company has reported total income of Rs. 781.40 crores during the period ended December 31, 2022


Dabur India consolidated Q3FY23 PAT lower at Rs. 475.94 Cr
News | February 03, 2023

Dabur India consolidated Q3FY23 PAT lower at Rs. 475.94 Cr

The company has posted net profit of Rs. 475.94 crores for the period ended December 31, 2022


Jubilant Ingrevia posts Q3FY23 consolidated PAT at Rs. 91.53 Cr
News | February 02, 2023

Jubilant Ingrevia posts Q3FY23 consolidated PAT at Rs. 91.53 Cr

The company has reported total income of Rs. 1165.31 crores during the period ended December 31, 2022


Hester Biosciences Q3 FY23 consolidated net profit up at Rs. 11.18 Cr
News | February 02, 2023

Hester Biosciences Q3 FY23 consolidated net profit up at Rs. 11.18 Cr

The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022


Jubilant’s Radiopharma business receives NDA approval for Technetium Mertiatide Injection
Drug Approval | February 02, 2023

Jubilant’s Radiopharma business receives NDA approval for Technetium Mertiatide Injection

The Tc 99m Mertiatide Injection is used in the diagnosis of congenital and acquired renal abnormalities


Balaxi Pharmaceuticals revenue up 40.3%
News | February 02, 2023

Balaxi Pharmaceuticals revenue up 40.3%

During the quarter, foreign exchange fluctuations had an impact of Rs. 4.56 crore Q3 FY23 Profit After Tax after considering exchange rate fluctuations stood at Rs. 8.2 crore


Budget 2023-24: Industry welcomes focus on medical research and pharma innovation
Policy | February 02, 2023

Budget 2023-24: Industry welcomes focus on medical research and pharma innovation

It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047


Lupin receives tentative approval from USFDA for DETAF tablets
Drug Approval | February 01, 2023

Lupin receives tentative approval from USFDA for DETAF tablets

DETAF would be a welcome new addition in the management of HIV infections and will be available for supplies to low- and middle-income countries